数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Zhanchang Xin Chairman of the Board and Chief Executive Officer 57 1.79万美元 1383.90 2024-02-15
Haiping Shi Chief Financial Officer and Director 51 1.46万美元 713.10 2024-02-15
Ming Jing Independent Director 61 未披露 未持股 2024-02-15
Maofan Tang Independent Director 27 未披露 未持股 2024-02-15
Dingqian Liu Executive Director 55 未披露 671.70 2024-02-15
Song Gao Independent Director 55 未披露 未持股 2024-02-15

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Zhanchang Xin Chairman of the Board and Chief Executive Officer 57 1.79万美元 1383.90 2024-02-15
Haiping Shi Chief Financial Officer and Director 51 1.46万美元 713.10 2024-02-15

董事简历

中英对照 |  中文 |  英文
Zhanchang Xin

Zhanchang Xin,Qilian International Holding Group Limited成立以来,一直担任Qilian International Holding Group Limited董事长兼首席执行官。2006年8月以来,他担任Gansu QLS。的董事会主席。曾在Gansu QLS。工作34年,在《中国医药工业杂志》、《甘肃医药》等中国医学期刊上发表药学研究论文。1986年6月,他获得兰州大学医学院药剂学学士学位。他于2004年12月获得北京工商大学工商管理硕士学位。


Zhanchang Xin,has been Qilian International Holding Group Limited Chairman of the Board and Chief Executive Officer since Qilian International Holding Group Limited incorporation. Since August 2006, Mr. Xin has served as Chairman of the Board of Gansu QLS. Mr. Xin has over 30 years of research and engineering in the pharmaceutical industry. He has worked for Gansu QLS for 34 years and has published pharmaceutical research papers in Chinese medical journals such as "China Medical Industry Journal" and "Gansu Pharmaceutical". In June 1986, Mr. Xin received a Bachelor Degree in Pharmacy from the School of Medicine at Lanzhou University. Mr. Xin received his Master Degree in Business Administration from Beijing Technology and Business University in December 2004.
Zhanchang Xin,Qilian International Holding Group Limited成立以来,一直担任Qilian International Holding Group Limited董事长兼首席执行官。2006年8月以来,他担任Gansu QLS。的董事会主席。曾在Gansu QLS。工作34年,在《中国医药工业杂志》、《甘肃医药》等中国医学期刊上发表药学研究论文。1986年6月,他获得兰州大学医学院药剂学学士学位。他于2004年12月获得北京工商大学工商管理硕士学位。
Zhanchang Xin,has been Qilian International Holding Group Limited Chairman of the Board and Chief Executive Officer since Qilian International Holding Group Limited incorporation. Since August 2006, Mr. Xin has served as Chairman of the Board of Gansu QLS. Mr. Xin has over 30 years of research and engineering in the pharmaceutical industry. He has worked for Gansu QLS for 34 years and has published pharmaceutical research papers in Chinese medical journals such as "China Medical Industry Journal" and "Gansu Pharmaceutical". In June 1986, Mr. Xin received a Bachelor Degree in Pharmacy from the School of Medicine at Lanzhou University. Mr. Xin received his Master Degree in Business Administration from Beijing Technology and Business University in December 2004.
Haiping Shi

Haiping Shi ,自2020年12月起担任Qilian International Holding Group Limited 董事,自2020年6月15日起担任Qilian International Holding Group Limited 首席财务官。自2018年4月起,她担任Gansu QLS的首席财务官兼财务部门负责人。2014年2月至2018年3月,她担任Gansu QLS财务部门负责人。2012年2月至2014年1月,她担任甘肃昆士兰大学财务处副处长。她于1995年7月获得甘肃广播电视大学三年制大专学位。2008年5月,她获得了中国人力资源和社会保障部、财政部颁发的会计中级资格证书。


Haiping Shi,has served as Qilian International Holding Group Limited director since December 2020 and as Qilian International Holding Group Limited Chief Financial Officer since June 15, 2020. Since April 2018, Ms. Shi has served as the Chief Financial Officer and Head of Financial Department for Gansu QLS. From February 2014 to March 2018, Ms. Shi served as the Head of Financial Department for Gansu QLS. From February 2012 to January 2014, Ms. Shi served as the Deputy General of Financial Department of Gansu QLS. Ms. Shi received a Three-Year College Degree from Gansu Radio and Television University in July 1995. She received an Accounting Intermediate Qualification Certificate awarded by China's Ministry of Human Resources and Social Security and China's Ministry of Finance in May 2008.
Haiping Shi ,自2020年12月起担任Qilian International Holding Group Limited 董事,自2020年6月15日起担任Qilian International Holding Group Limited 首席财务官。自2018年4月起,她担任Gansu QLS的首席财务官兼财务部门负责人。2014年2月至2018年3月,她担任Gansu QLS财务部门负责人。2012年2月至2014年1月,她担任甘肃昆士兰大学财务处副处长。她于1995年7月获得甘肃广播电视大学三年制大专学位。2008年5月,她获得了中国人力资源和社会保障部、财政部颁发的会计中级资格证书。
Haiping Shi,has served as Qilian International Holding Group Limited director since December 2020 and as Qilian International Holding Group Limited Chief Financial Officer since June 15, 2020. Since April 2018, Ms. Shi has served as the Chief Financial Officer and Head of Financial Department for Gansu QLS. From February 2014 to March 2018, Ms. Shi served as the Head of Financial Department for Gansu QLS. From February 2012 to January 2014, Ms. Shi served as the Deputy General of Financial Department of Gansu QLS. Ms. Shi received a Three-Year College Degree from Gansu Radio and Television University in July 1995. She received an Accounting Intermediate Qualification Certificate awarded by China's Ministry of Human Resources and Social Security and China's Ministry of Finance in May 2008.
Ming Jing

Ming Jing 自2020年12月起担任Qilian International Holding Group Limited 独立董事。2003年至今,任甘肃中医药大学药学院教授、博士研究生导师、副院长,在《科学引文索引》SCI、《中国科学引文数据库》(CSCD)等著名科学期刊发表研究论文70余篇。迄今为止,他还获得了6项国家专利证书,成为第一发明人。他于1986年获得兰州大学学士学位。


Ming Jing,has served as Qilian International Holding Group Limited independent director since December 2020. From 2003 to present, Mr. Jing has been a professor, doctorate degree tutor and associate Dean of the School of Pharmacy at Gansu University of Traditional Chinese Medicine and published more than seventy research papers on prominent science journals such as Science Citation Index (SCI) and Chinese Science Citation Database (CSCD). To date, Mr. Jing has also obtained 6 National Patent Certificates as a first inventor. Mr. Jing earned a Bachelor's Degree from Lanzhou University in 1986.
Ming Jing 自2020年12月起担任Qilian International Holding Group Limited 独立董事。2003年至今,任甘肃中医药大学药学院教授、博士研究生导师、副院长,在《科学引文索引》SCI、《中国科学引文数据库》(CSCD)等著名科学期刊发表研究论文70余篇。迄今为止,他还获得了6项国家专利证书,成为第一发明人。他于1986年获得兰州大学学士学位。
Ming Jing,has served as Qilian International Holding Group Limited independent director since December 2020. From 2003 to present, Mr. Jing has been a professor, doctorate degree tutor and associate Dean of the School of Pharmacy at Gansu University of Traditional Chinese Medicine and published more than seventy research papers on prominent science journals such as Science Citation Index (SCI) and Chinese Science Citation Database (CSCD). To date, Mr. Jing has also obtained 6 National Patent Certificates as a first inventor. Mr. Jing earned a Bachelor's Degree from Lanzhou University in 1986.
Maofan Tang

Maofan Tang自2019年1月起在北京Topson律师事务所担任审计专业人员和中层管理职位,协助审计计划和执行,分析财务报表,评估内部控制,维护准确的审计文件,确保遵守法规,管理审计团队,沟通审计结果,并保持与行业标准的更新。Tang先生于2018年3月至2018年12月担任Chengdu Shangtou Jinsheng Equity Investment Fund Management Co., Ltd.的投资经理,负责进行投资分析,管理投资组合,配置资产,降低风险,做出投资决策,监督合规性,提供业绩报告等。从2017年4月到2018年3月,他担任Tianfeng Securities Co.的研究员,在那里他分析财务数据,监测市场趋势,并为客户提供见解,以便在二级市场做出明智的投资决策。他于2019年获得悉尼大学金融和大数据研究生学位。他于2017年获得Monash University银行和金融学士学位。


Maofan Tang,has served as Qilian International Holding Group Limited independent director since June 2023. He has been working as an auditing professional and serving in a middle management position at Beijing Topson LLP since January 2019. Mr. Tang served as an investment manager at Chengdu Shangtou Jinsheng Equity Investment Fund Management Co., Ltd. from March 2018 to December 2018, where he conducted investment analysis, managed investment portfolios, allocated assets, mitigated risks, made investment decisions, oversaw compliance, provided performance reporting, etc. From April 2017 to March 2018, Mr. Tang served as a researcher at Tianfeng Securities Co. Mr. Tang received his postgraduate degree in Finance and Big Data from the University of Sydney in 2019. He received his Bachelor's Degree in Banking and Finance from Monash University in 2017.
Maofan Tang自2019年1月起在北京Topson律师事务所担任审计专业人员和中层管理职位,协助审计计划和执行,分析财务报表,评估内部控制,维护准确的审计文件,确保遵守法规,管理审计团队,沟通审计结果,并保持与行业标准的更新。Tang先生于2018年3月至2018年12月担任Chengdu Shangtou Jinsheng Equity Investment Fund Management Co., Ltd.的投资经理,负责进行投资分析,管理投资组合,配置资产,降低风险,做出投资决策,监督合规性,提供业绩报告等。从2017年4月到2018年3月,他担任Tianfeng Securities Co.的研究员,在那里他分析财务数据,监测市场趋势,并为客户提供见解,以便在二级市场做出明智的投资决策。他于2019年获得悉尼大学金融和大数据研究生学位。他于2017年获得Monash University银行和金融学士学位。
Maofan Tang,has served as Qilian International Holding Group Limited independent director since June 2023. He has been working as an auditing professional and serving in a middle management position at Beijing Topson LLP since January 2019. Mr. Tang served as an investment manager at Chengdu Shangtou Jinsheng Equity Investment Fund Management Co., Ltd. from March 2018 to December 2018, where he conducted investment analysis, managed investment portfolios, allocated assets, mitigated risks, made investment decisions, oversaw compliance, provided performance reporting, etc. From April 2017 to March 2018, Mr. Tang served as a researcher at Tianfeng Securities Co. Mr. Tang received his postgraduate degree in Finance and Big Data from the University of Sydney in 2019. He received his Bachelor's Degree in Banking and Finance from Monash University in 2017.
Dingqian Liu

Dingqian Liu自2006年8月起担任Gansu Qilianshan Pharmaceutical Co., Ltd.总经理,领导董事会决策在经营层面的执行,制定生产经营计划,确保生产目标的完成。自2019年1月以来,Liu先生一直担任Gansu Qilianshan Pharmaceutical Co., Ltd.监事会主席,审查财务状况,监督高管的行为,并维护公司的商业福利。他于2006年7月毕业于中国中央教育学院,获得经济管理学士学位。他于2003年7月获得甘肃省高等专科学校经济管理副学士学位。


Dingqian Liu,has served as Qilian International Holding Group Limited executive director since June 2023. He has been serving as the general manager for Gansu Qilianshan Pharmaceutical Co., Ltd. since August 2006, leading the execution of the board of directors' decisions at the business level, formulating the production and operation plans, and ensuring the completion of production goals. Since January 2019, Mr. Liu has been serving as the Chairman of the Supervisory Board for Gansu Qilianshan Pharmaceutical Co., Ltd., examining financial conditions, supervising executives' conduct, and safeguarding the company's business welfare in general. Mr. Liu graduated from the Central Academy of Education of China with a Bachelor's Degree in Economic Management in July 2006. He received his Associate Degree in Economic Management from Gansu Provincial College in July 2003.
Dingqian Liu自2006年8月起担任Gansu Qilianshan Pharmaceutical Co., Ltd.总经理,领导董事会决策在经营层面的执行,制定生产经营计划,确保生产目标的完成。自2019年1月以来,Liu先生一直担任Gansu Qilianshan Pharmaceutical Co., Ltd.监事会主席,审查财务状况,监督高管的行为,并维护公司的商业福利。他于2006年7月毕业于中国中央教育学院,获得经济管理学士学位。他于2003年7月获得甘肃省高等专科学校经济管理副学士学位。
Dingqian Liu,has served as Qilian International Holding Group Limited executive director since June 2023. He has been serving as the general manager for Gansu Qilianshan Pharmaceutical Co., Ltd. since August 2006, leading the execution of the board of directors' decisions at the business level, formulating the production and operation plans, and ensuring the completion of production goals. Since January 2019, Mr. Liu has been serving as the Chairman of the Supervisory Board for Gansu Qilianshan Pharmaceutical Co., Ltd., examining financial conditions, supervising executives' conduct, and safeguarding the company's business welfare in general. Mr. Liu graduated from the Central Academy of Education of China with a Bachelor's Degree in Economic Management in July 2006. He received his Associate Degree in Economic Management from Gansu Provincial College in July 2003.
Song Gao

Song Gao是一位经验丰富的专业人士,她的职业生涯跨越了30多年。她在保险、珠宝、互联网金融和IPO咨询等多个行业积累了丰富的经验。自2020年7月起,高女士担任深圳德音国际文化传媒有限公司董事长。2017年3月至2020年3月,高女士担任亚洲时代(深圳)有限公司总裁和亚洲美国咨询(深圳)有限公司董事长。自2004年以来,高女士一直担任职业经理人,熟练地在不同行业和行业中穿行。她在高层组织设计、股权结构和商业模式开发方面拥有丰富的经验。1987年至2004年间,高女士在平安保险公司工作,先后担任秘书、人力资源、承保管理和地区管理等职务。高女士在天津大学获得经济管理硕士学位。


Song Gao,has served as Qilian International Holding Group Limited independent director since July 2023. Since July 2020, Ms. Gao has served as the Chairwoman of Shenzhen Deyin International Culture Media Co., Ltd. From March 2017 to March 2020, Ms. Gao served as the President of Asia Times (Shenzhen) Co., Ltd. and the Chairwoman of Asia America Consulting (Shenzhen) Co., Ltd. Since 2004, Ms. Gao has been a career manager, adeptly navigating through different sectors and industries. She has experience in high-level organizational design, equity structuring, and business model development. Between 1987 and 2004, Ms. Gao served at Ping An Insurance Company, where she progressed through roles in secretarial work, human resources, underwriting management, and regional management.
Song Gao是一位经验丰富的专业人士,她的职业生涯跨越了30多年。她在保险、珠宝、互联网金融和IPO咨询等多个行业积累了丰富的经验。自2020年7月起,高女士担任深圳德音国际文化传媒有限公司董事长。2017年3月至2020年3月,高女士担任亚洲时代(深圳)有限公司总裁和亚洲美国咨询(深圳)有限公司董事长。自2004年以来,高女士一直担任职业经理人,熟练地在不同行业和行业中穿行。她在高层组织设计、股权结构和商业模式开发方面拥有丰富的经验。1987年至2004年间,高女士在平安保险公司工作,先后担任秘书、人力资源、承保管理和地区管理等职务。高女士在天津大学获得经济管理硕士学位。
Song Gao,has served as Qilian International Holding Group Limited independent director since July 2023. Since July 2020, Ms. Gao has served as the Chairwoman of Shenzhen Deyin International Culture Media Co., Ltd. From March 2017 to March 2020, Ms. Gao served as the President of Asia Times (Shenzhen) Co., Ltd. and the Chairwoman of Asia America Consulting (Shenzhen) Co., Ltd. Since 2004, Ms. Gao has been a career manager, adeptly navigating through different sectors and industries. She has experience in high-level organizational design, equity structuring, and business model development. Between 1987 and 2004, Ms. Gao served at Ping An Insurance Company, where she progressed through roles in secretarial work, human resources, underwriting management, and regional management.

高管简历

中英对照 |  中文 |  英文
Zhanchang Xin

Zhanchang Xin,Qilian International Holding Group Limited成立以来,一直担任Qilian International Holding Group Limited董事长兼首席执行官。2006年8月以来,他担任Gansu QLS。的董事会主席。曾在Gansu QLS。工作34年,在《中国医药工业杂志》、《甘肃医药》等中国医学期刊上发表药学研究论文。1986年6月,他获得兰州大学医学院药剂学学士学位。他于2004年12月获得北京工商大学工商管理硕士学位。


Zhanchang Xin,has been Qilian International Holding Group Limited Chairman of the Board and Chief Executive Officer since Qilian International Holding Group Limited incorporation. Since August 2006, Mr. Xin has served as Chairman of the Board of Gansu QLS. Mr. Xin has over 30 years of research and engineering in the pharmaceutical industry. He has worked for Gansu QLS for 34 years and has published pharmaceutical research papers in Chinese medical journals such as "China Medical Industry Journal" and "Gansu Pharmaceutical". In June 1986, Mr. Xin received a Bachelor Degree in Pharmacy from the School of Medicine at Lanzhou University. Mr. Xin received his Master Degree in Business Administration from Beijing Technology and Business University in December 2004.
Zhanchang Xin,Qilian International Holding Group Limited成立以来,一直担任Qilian International Holding Group Limited董事长兼首席执行官。2006年8月以来,他担任Gansu QLS。的董事会主席。曾在Gansu QLS。工作34年,在《中国医药工业杂志》、《甘肃医药》等中国医学期刊上发表药学研究论文。1986年6月,他获得兰州大学医学院药剂学学士学位。他于2004年12月获得北京工商大学工商管理硕士学位。
Zhanchang Xin,has been Qilian International Holding Group Limited Chairman of the Board and Chief Executive Officer since Qilian International Holding Group Limited incorporation. Since August 2006, Mr. Xin has served as Chairman of the Board of Gansu QLS. Mr. Xin has over 30 years of research and engineering in the pharmaceutical industry. He has worked for Gansu QLS for 34 years and has published pharmaceutical research papers in Chinese medical journals such as "China Medical Industry Journal" and "Gansu Pharmaceutical". In June 1986, Mr. Xin received a Bachelor Degree in Pharmacy from the School of Medicine at Lanzhou University. Mr. Xin received his Master Degree in Business Administration from Beijing Technology and Business University in December 2004.
Haiping Shi

Haiping Shi ,自2020年12月起担任Qilian International Holding Group Limited 董事,自2020年6月15日起担任Qilian International Holding Group Limited 首席财务官。自2018年4月起,她担任Gansu QLS的首席财务官兼财务部门负责人。2014年2月至2018年3月,她担任Gansu QLS财务部门负责人。2012年2月至2014年1月,她担任甘肃昆士兰大学财务处副处长。她于1995年7月获得甘肃广播电视大学三年制大专学位。2008年5月,她获得了中国人力资源和社会保障部、财政部颁发的会计中级资格证书。


Haiping Shi,has served as Qilian International Holding Group Limited director since December 2020 and as Qilian International Holding Group Limited Chief Financial Officer since June 15, 2020. Since April 2018, Ms. Shi has served as the Chief Financial Officer and Head of Financial Department for Gansu QLS. From February 2014 to March 2018, Ms. Shi served as the Head of Financial Department for Gansu QLS. From February 2012 to January 2014, Ms. Shi served as the Deputy General of Financial Department of Gansu QLS. Ms. Shi received a Three-Year College Degree from Gansu Radio and Television University in July 1995. She received an Accounting Intermediate Qualification Certificate awarded by China's Ministry of Human Resources and Social Security and China's Ministry of Finance in May 2008.
Haiping Shi ,自2020年12月起担任Qilian International Holding Group Limited 董事,自2020年6月15日起担任Qilian International Holding Group Limited 首席财务官。自2018年4月起,她担任Gansu QLS的首席财务官兼财务部门负责人。2014年2月至2018年3月,她担任Gansu QLS财务部门负责人。2012年2月至2014年1月,她担任甘肃昆士兰大学财务处副处长。她于1995年7月获得甘肃广播电视大学三年制大专学位。2008年5月,她获得了中国人力资源和社会保障部、财政部颁发的会计中级资格证书。
Haiping Shi,has served as Qilian International Holding Group Limited director since December 2020 and as Qilian International Holding Group Limited Chief Financial Officer since June 15, 2020. Since April 2018, Ms. Shi has served as the Chief Financial Officer and Head of Financial Department for Gansu QLS. From February 2014 to March 2018, Ms. Shi served as the Head of Financial Department for Gansu QLS. From February 2012 to January 2014, Ms. Shi served as the Deputy General of Financial Department of Gansu QLS. Ms. Shi received a Three-Year College Degree from Gansu Radio and Television University in July 1995. She received an Accounting Intermediate Qualification Certificate awarded by China's Ministry of Human Resources and Social Security and China's Ministry of Finance in May 2008.